This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Kathrin Hammon
Account Manager at Genovac


Prior to joining Genovac, Kathrin conducted her postdoctoral research on different designs and specificities of leukemia-specific CAR T cells at the Leibniz Institute for Immunotherapy in Regensburg, Germany. Kathrin joined Genovac as an Account Manager in 2022. She is responsible for overseeing client antibody discovery projects from target accession numbers to fully characterized antibodies. During her PhD she investigated the immune modulatory effect of a tumor metabolite on primary leukemia and immune cells.

Agenda Sessions

  • Enhance and Expand Anti-ID Antibody Diversity and Affinity Through Genetic Immunization